Innovative solutions to novel drug development in mental health
MetadataShow full item record
Altmetrics Handle Statistics
Altmetrics DOI Statistics
There are many new advances in neuroscience and mental health which should lead to a greater understanding of the neurobiological dysfunction in neuropsychiatric disorders and new developments for early, effective treatments. To do this, a biomarker approach combining genetic, neuroimaging, cognitive and other biological measures is needed. The aim of this article is to highlight novel approaches for pharmacological and non-pharmacological treatment development. This article suggests approaches that can be taken in the future including novel mechanisms with preliminary clinical validation to provide a toolbox for mechanistic studies and also examples of translation and back-translation. The review also emphasizes the need for clinician-scientists to be trained in a novel way in order to equip them with the conceptual and experimental techniques required, and emphasizes the need for private-public partnership and pre-competitive knowledge exchange. This should lead the way for important new holistic treatment developments to improve cognition, functional outcome and well-being of people with neuropsychiatric disorders.
Insel , T R , Voon , V , Nye , J S , Brown , V J , Altevogt , B M , Bullmore , E T , Goodwin , G M , Howard , R J , Kupfer , D J , Malloch , G , Marston , H M , Nutt , D J , Robbins , T W , Stahl , S M , Tricklebank , M D , Williams , J H & Sahakian , B J 2013 , ' Innovative solutions to novel drug development in mental health ' , Neuroscience and Biobehavioral Reviews , vol. 37 , no. 10 Part 1 , pp. 2438-2444 . https://doi.org/10.1016/j.neubiorev.2013.03.022
Neuroscience and Biobehavioral Reviews
© 2013 Elsevier Ltd. All rights reserved. Published as open access.
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.